Vitalgen closed 300 million RMB Series A funding round

（Shanghai, China, May 25, 2021）, Shanghai Vitalgen BioPharma Co., Ltd. has raised 300 million RMB in its Series A funding round. The financing is led by Loyal Valley Capital, with participation from Jifeng Ventures and IDG. 

The funding will be used to develop our technology platforms and research pipelines.